NeoImmuneTech to Partner with U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for Drug Development in Acute Radiation Syndrome (ARS)
/PRNewswire/ -- NeoImmuneTech, Inc. (NIT or "NeoImmuneTech"), a clinical-stage T cell-focused biopharmaceutical company, today announced an agreement with the...
Alexandraa Wolfarth Bennyj Chen Sara Ferrando Yujing Zou Radiation Research Society Benny Chen At Duke University
Source: prnewswire.com